CR

Craven House Capital PLCLSE Craven House Stock Report

Last reporting period 30 Nov, 2022

Updated 14 Oct, 2024

Last price

Market cap $B

0.001

Micro

Exchange

XLON - London Stock Exchange

CRV.L Stock Analysis

CR

Uncovered

Craven House Capital PLC is uncovered by Eyestock quantitative analysis.

Market cap $B

0.001

Dividend yield

Shares outstanding

3.864 B

Craven House Capital Plc seeks to acquire businesses in emerging and developed markets. The firm operates through the investing activities segment. The firm's investing policy is primarily to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses, or other assets participating in the e-commerce sector. Its investment portfolio comprises Garimon Limited, which is a private investment holding company and has an investment portfolio that includes public and private companies in Latin America, Asia, Africa and Eastern Europe; Rosedog Limited; Honeydog Limited and Bio Vitos Medical Limited. The Company’s investment manager is Desmond Holdings Ltd.

View Section: Eyestock Rating